» Articles » PMID: 39255296

Developing an Ensemble Machine Learning Study: Insights from a Multi-center Proof-of-concept Study

Abstract

Background: To address the numerous unmeet clinical needs, in recent years several Machine Learning models applied to medical images and clinical data have been introduced and developed. Even when they achieve encouraging results, they lack evolutionary progression, thus perpetuating their status as autonomous entities. We postulated that different algorithms which have been proposed in the literature to address the same diagnostic task, can be aggregated to enhance classification performance. We suggested a proof of concept to define an ensemble approach useful for integrating different algorithms proposed to solve the same clinical task.

Methods: The proposed approach was developed starting from a public database consisting of radiomic features extracted from CT images relating to 535 patients suffering from lung cancer. Seven algorithms were trained independently by participants in the AI4MP working group on Artificial Intelligence of the Italian Association of Physics in Medicine to discriminate metastatic from non-metastatic patients. The classification scores generated by these algorithms are used to train SVM classifier. The Explainable Artificial Intelligence approach is applied to the final model. The ensemble model was validated following an 80-20 hold-out and leave-one-out scheme on the training set.

Results: Compared to individual algorithms, a more accurate result was achieved. On the independent test the ensemble model achieved an accuracy of 0.78, a F1-score of 0.57 and a log-loss of 0.49. Shapley values representing the contribution of each algorithm to the final classification result of the ensemble model were calculated. This information represents an added value for the end user useful for evaluating the appropriateness of the classification result on a particular case. It also allows us to evaluate on a global level which methodological approaches of the individual algorithms are likely to have the most impact.

Conclusion: Our proposal represents an innovative approach useful for integrating different algorithms that populate the literature and which lays the foundations for future evaluations in broader application scenarios.

References
1.
Kirienko M, Cozzi L, Rossi A, Voulaz E, Antunovic L, Fogliata A . Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions. Eur J Nucl Med Mol Imaging. 2018; 45(10):1649-1660. DOI: 10.1007/s00259-018-3987-2. View

2.
Massafra R, Latorre A, Fanizzi A, Bellotti R, Didonna V, Giotta F . A Clinical Decision Support System for Predicting Invasive Breast Cancer Recurrence: Preliminary Results. Front Oncol. 2021; 11:576007. PMC: 7991309. DOI: 10.3389/fonc.2021.576007. View

3.
Corti C, Cobanaj M, Dee E, Criscitiello C, Tolaney S, Celi L . Artificial intelligence in cancer research and precision medicine: Applications, limitations and priorities to drive transformation in the delivery of equitable and unbiased care. Cancer Treat Rev. 2022; 112:102498. DOI: 10.1016/j.ctrv.2022.102498. View

4.
Cai Z, Xu D, Zhang Q, Zhang J, Ngai S, Shao J . Classification of lung cancer using ensemble-based feature selection and machine learning methods. Mol Biosyst. 2014; 11(3):791-800. DOI: 10.1039/c4mb00659c. View

5.
Massafra R, Fanizzi A, Amoroso N, Bove S, Comes M, Pomarico D . Analyzing breast cancer invasive disease event classification through explainable artificial intelligence. Front Med (Lausanne). 2023; 10:1116354. PMC: 9932275. DOI: 10.3389/fmed.2023.1116354. View